Elevation Oncology Inc(NASDAQ:ELEV) 
Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a cl...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-01-23
P
O 0.67
H 0.79
L 0.64
C 0.66
V 2,599,164
10EMA 0.66
20EMA 0.66
60EMA 0.66
120EMA 0.66
250EMA 0.66